2‐phenylethynesulphonamide (PFT‐μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP‐AUY922 in melanoma, by reducing GSH levels
Andrée Yeramian(Universitat de Lleida), A. Martínez Vea(Universitat de Lleida), Mónica Domingo(Universitat de Lleida), Xavier Dolcet(Universitat de Lleida), Óscar Maiques(Institute of Cancer Research), Sandra Benítez(Universitat de Lleida), Xavier Matías‐Guiu(Universitat de Lleida), Joan Ribera(Universitat de Lleida), Elisa Cabiscol(Universitat de Lleida), Marı́a Santacana(Universitat de Lleida), Montserrat Martinez(Universitat de Lleida), Joan Valls(Universitat Autònoma de Barcelona), R. Vilella(Hospital Clínic de Barcelona)
Cited by 24
Related Papers
SNPStats: a web tool for the analysis of association studies
|Bioinformatics|2006|2k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
|Annals of Oncology|2020|478
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
|Journal of Clinical Investigation|2012|462